Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x100px
Document › Details

c-LEcta GmbH. (1/26/17). "Press Release: c-LEcta Starts Marketing & Distribution of Denarase".

Organisations Organisation c-LEcta GmbH
  Group Kerry Group (Group)
  Organisation 2 Sartorius Stedim Biotech GmbH (SSB)
  Group Sartorius (Group)
Products Product Denarase®
  Product 2 biopharmaceutical

DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.

DENARASE® from Serratia marcenses is a highly active nuclease that is used to remove interfering DNA and RNA from fermentation batches e.g. during the production of vaccines and biopharmaceuticals.

The advantages of DENARASE® are:

+ Animal product free production

+ endotoxin-free production strain

+ high purity and activity

+ compliance with cGMP

If you are interested in testing our DENARASE or if you need further information, please do not hesitate to contact us via

Record changed: 2023-06-05


Picture EBD Group ChinaBio Partnering Forum 2023 Shanghai 650x200px

More documents for Kerry Group (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top